• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

biotech IPO

Wall Street stock exchange finance shares share price Nasdaq
Biotech

LB Pharma upsizes IPO in 1st biotech listing since February

LB’s decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing.
James Waldron Sep 11, 2025 4:09am
dollars money ocean dollar bill

LB Pharmaceuticals eyes $228M in IPO cash

Sep 8, 2025 3:16pm
Money frozen in ice

CNS biotech attempts to break the IPO ice

Aug 25, 2025 11:10am
HKEX

Leads Biolabs hits Hong Kong stock exchange in $189M IPO

Jul 25, 2025 10:59am
illustration of young entrepreneur pitching idea to raise venture capital fund

Taxes, tariffs, interest rates hold key to biotech's future: EY

Jun 18, 2025 9:50am
Wall Street stock exchange finance shares share price Nasdaq

Odyssey abandons IPO plans as 'not in best interests of company'

Jun 10, 2025 7:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings